Hepatitis Monthly

Published by: Kowsar

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with ?-interferon and ribavirin

Michele Malaguarnera 1 , * , Marco Vacante 2 , Cristina Russo 2 , Maria Pia Gargante 2 , Maria Giordano 2 , Gaetano Bertino 2 , Sergio Neri 2 , Mariano Malaguarnera 2 , Fabio Galvano 2 and Giovanni Li Volti 2
Authors Information
1 Department of Biochemistry, Medical Chemistry and Molecular Biology, University of Catania, malaguar@unict.it, Italy
2 Department of Internal Medicine and Systemic diseases, University of Catania, Italy
Article information
  • Hepatitis Monthly: , 11 (2); 92-98
  • Article Type: Research Article
  • Received: February 15, 2010
  • Accepted: August 14, 2010

To Cite: Malaguarnera M, Vacante M, Russo C, Gargante M, Giordano M, et al. Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with ?-interferon and ribavirin, Hepat Mon. Online ahead of Print ;11(2):92-98.

Abstract
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments